Sandoz’s Zarxio: Updated Interactive Timeline Of Regulatory And Legal Milestones
Executive Summary
Timeline presents visual overview of key events for the first biosimilar approved under the U.S. 351(k) pathway, including recent appeals court decision in Sandoz's legal dispute with Amgen.